enGene Therapeutics Inc. (ENGN)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 82
-0.1
-5.2083%
$
97.01M Market Cap
- P/E Ratio
- Div Yield
798,900 Volume
- Eps
$ 1.92
Previous Close Want to track ENGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
enGene Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 173,391 | $1.12M | $326,842.03 | -$790,657.65 | -70.75% |
| NM Nir Messafi Deep Track Capita LLP | 4.38M | $34.19M | $8.25M | -$25.93M | -75.86% |
| KJ Ken Joseph Braidwel LLP | 2.46M | $18.68M | $4.59M | -$14.09M | -75.41% |
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 163 | $1,110 | $313.35 | -$796.65 | -71.77% |
| IM Ilko Menkov Vestal Point Capita LLP | 2.17M | $16.21M | $4.14M | -$12.07M | -74.48% |
 David Vollmer PFS Partners, LLC | 11,000 | $79,530 | $21,175 | -$58,355 | -73.37% |
 Raymond Debbane Siren, L.L.C. | 5.25M | $43.18M | $10.11M | -$33.07M | -76.58% |
